Agile Therapeutics Stock Price (NASDAQ:AGRX)

Add to My Stocks
$0.34 $0.03 (8.11%) AGRX stock closing price Sep 19, 2018 (Closing)
Prev Close* : $0.37
Market Cap:
Day Low: $0.33
52 Week Low: $0.23
Open: $0.35
Volume: -
Day High: $0.37
52 Week High: $5.40

Latest Stock Market News

Latest Articles

Agile Therapeutics News - From Partners

AGRX Stockcharts

View AGRX PE ratio, PS ratio stocks charts and compare with peers.
AGRX Chart
Note: Compare Agile Therapeutics stock price history with the index and industry peers.

Agile Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Agile Therapeutics Returns

(return on equity)

Agile Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

AGRX Industry Peers

Company Price Change (%)
Versartis (VSAR)1.430.03 (2.14%)
Acasti Pharma (ACST)0.560.02 (3.7%)
Pfizer (PFE)43.260.25 (0.57%)
Merck (MRK)69.980.44 (0.62%)
Juniper Pharma (JNP)11.50 (0%)
Palatin Technologies (PTN)1.030.01 (0.98%)
Johnson & Johnson (JNJ)140.460.08 (0.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)6.420.42 (7%)
Supernus Pharma (SUPN)47.91 (2.13%)
Mylan (MYL)38.240.43 (1.14%)
BAUSCH HEALTH (BHC)24.070.26 (1.09%)
Allergan (AGN)188.031.96 (1.05%)
Dr. Reddy's Laboratories (RDY)36.20.35 (0.98%)
Adamas Pharma (ADMS)18.820.15 (0.8%)
Top gainers from Medical-Generic Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
Mallinckrodt (MNK)29.680.11 (0.37%)
Corium (CORI)8.920.01 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Sep 19, 2018

Agile Therapeutics Inc Stock News - Partner Headlines

Agile Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-28.3M-28.74M-30.33M-16.07M-14.32M
Total Operating Expense26.8M29.71M33.08M18.51M12.72M
View Agile Therapeutics income statement
balance sheet20172016201520142013
Total Assets50.59M63.86M50.71M54.82M14.4M
Total Liabilities14.27M21.57M20.96M18.82M85.84M
Shareholders Equity36.32M42.28M29.74M36M-71.44M
View Agile Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.45M1.28M---0.34M
Net Cash from (used by) Operating Activities-24.56M-23.3M-25.47M-14.5M-13.01M
Increase (Decrease) in Prop Plant And Equipment-1.31M-0.03M-0.29M-0.09M-4.94M
View Agile Therapeutics cash flow statement

Agile Therapeutics Stock Message Board

Agile Therapeutics stock lost 8.11%, and the last close price as of Sep 19, 2018 is $0.34 for AGRX stock. Stock price or share price can be used to find the total market value of a company. Agile Therapeutics market cap stands at $12.72M as of Sep 19, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Agile Therapeutics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Agile Therapeutics is worth a lot, it will most likely be reflected in an inflated Agile Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1,479,845 shares were traded with a closing stock price of $0.34 as of Sep 19, 2018, as can be seen from Agile Therapeutics stock quote. One can view Agile Therapeutics stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Agile Therapeutics stock dividend was 0.00 during the last quarter. Agile Therapeutics stock price history, gives the entire historical data for AGRX stock.